Free press releases distribution network?

Agency / Source: Randox Laboratories Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Randox Introduces Practical Solutions for Translational Science - The sole purpose of translational science is to transfer scientific discoveries made in ‘basic research’ to clinical reality, to improve the health of individuals and reduce suffering - RandoxPharmaServices.com
Randox Introduces Practical Solutions for Translational Science

 

PRZOOM - /newswire/ - Crumlin, Antrim, United Kingdom, 2011/05/23 - The sole purpose of translational science is to transfer scientific discoveries made in ‘basic research’ to clinical reality, to improve the health of individuals and reduce suffering - RandoxPharmaServices.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Randox Pharma Services was founded with such a translational mission, and for 30 years has been carrying out R&D, custom assay development and supplying diagnostic solutions; all underpinned by a strong commitment to collaborate with leading academic research centres and pharmaceutical companies globally.

In recognition of the vital role biomarkers play in translational medicine, Randox Pharma Services supply an unrivalled range of single analyte and multiplex diagnostic kits direct to end user laboratories. Indeed, even kits produced primarily for research come under the same scrutiny as any commercial IVD assay i.e. imprecision less than 10%, fully optimised to eliminate cross-reactivity and non-specific binding to name just a few of our stringent QA processes.

As a private company Randox Pharma Services can be flexible and are swift to focus our significant in-house resources and expertise towards any pressing healthcare need; with a particular focus on oncology, infectious disease and metabolic disorders.

To enable this Randox have developed Biochip Array Technology, a multiplex technology which allows the simultaneous detection of multiple biomarkers from a single patient sample. Given the increased value of multiple biomarkers to improve patient diagnosis, such a technology is the ideal ‘target platform’ for translational science. Already arrays have been developed which are applicable to a broad range of therapeutic areas, with applications including multiplex immunoassays and nucleic acid based SNP, mutation, gene expression and pathogen detection arrays.

Randox Pharma Services (randoxpharmaservices.com) also offer over 130 enzymatic, substrate and immunoturbidimetric assays on our class-leading range of RX Series chemistry analysers which provide quality results at every phase from pre-clinical testing through to the clinic.

With robust, fit-for-purpose assays a pre-requisite for research, biomarker validation and ultimately translational science, only an established clinical diagnostic company such as Randox has the scientific and regulatory experience required. All to meet the pressing need for the more rapid translation of novel biomarkers to clinical utility.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Randox Laboratories Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Randox Introduces Practical Solutions for Translational Science

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Charlotte Jess - Randox.com 
+44(0)28 4245 7832 pharmaservices[.]randox.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Randox Laboratories Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Randox Laboratories Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today